Mark Heinen - 13 Dec 2021 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Head of Finance and interim Chief Financial Officer
Signature
/s/ Mark Heinen
Issuer symbol
BTTX on OTC
Transactions as of
13 Dec 2021
Net transactions value
+$16,400
Form type
4
Filing time
15 Dec 2021, 15:53:32 UTC
Previous filing
01 Nov 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $2,725 +500 +7.5% $5.45* 7,167 13 Dec 2021 Direct F1
transaction BTTX Common Stock Purchase $2,721 +500 +7% $5.44* 7,667 14 Dec 2021 Direct
transaction BTTX Common Stock Purchase $10,953 +2,333 +30% $4.70* 10,000 15 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021.

Remarks:

Head of Finance and interim Chief Financial Officer